cysteine has been researched along with Leukemia, Myeloid, Acute in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Adès, L; Alexe, G; Belloucif, Y; Benaksas, C; Berrou, J; Braun, T; Castelli, FA; Chat, L; Chauvel, C; Clappier, E; Dal Bello, R; de Thé, H; Dombret, H; Duchmann, M; Fenaille, F; Fenouille, N; Forget, A; Gardin, C; Huntly, BJ; Itzykson, R; Joudinaud, R; Laiguillon, MC; Ling, F; Lobry, C; Meduri, E; Pacchiardi, K; Pardieu, B; Pasanisi, J; Penneroux, J; Puissant, A; Raffoux, E; Sodaro, G; Stegmaier, K; Su, A; Vaganay, C; Vasseur, L; Wu, HC | 1 |
He, C; Jiang, L; Meng, Y; Tong, T; Wang, K; Wang, L; Wu, J; Xu, X; You, X; Yu, Y; Zhang, W; Zhao, M | 1 |
Aitken, RJ; Alvaro, F; Cain, JE; Chamberlain, J; de Bock, CE; De Iuliis, G; Douglas, AM; Duchatel, RJ; Dun, MD; Enjeti, AK; Findlay, IJ; Germon, ZP; Huang, H; Huang, Y; Jackson, ER; Larsen, MR; Lee, H; Lock, RB; Mannan, A; McEwen, HP; McLachlan, T; Melo-Braga, MN; Murray, HC; Nixon, B; Plank, MW; Schjenken, JE; Sillar, JR; Skerrett-Byrne, DA; Staudt, D; Vaghjiani, V; Verrills, NM; Wei, AH | 1 |
Bottomly, D; Hantschel, O; Kükenshöner, T; McWeeney, SK; Means, S; Medeiros, BC; Schultz, AR; Tyner, JW; Watanabe-Smith, K; Wilmot, B; Zhang, H | 1 |
Coulibaly, A; Haas, A; Jakobs, A; Klempnauer, KH; Schmidt, TJ; Steinmann, S | 1 |
Andreeff, M; Baran, N; Bhattacharya, S; Borthakur, G; Crews, CM; Davis, RE; Ishizawa, J; Kantarjian, H; Konopleva, M; Lorenzi, PL; McQueen, T; Mu, H; Piya, S; Qian, Y; Ruvolo, V; Wang, Z; You, MJ | 1 |
Culp-Hill, R; D'Alessandro, A; DeGregori, J; Gustafson, A; Jones, CL; Jordan, CT; Khan, N; Pei, S; Pollyea, DA; Reisz, JA; Stevens, BM | 1 |
Sarry, JE; Stuani, L | 1 |
Benjamin, DR; Bernstein, ID; Burke, PJ; Drachman, JG; Harrington, KH; Jeffrey, SC; Klussman, K; Kostner, H; Kung Sutherland, MS; Lyon, RP; McEarchern, JA; Meyer, D; Ryan, MC; Senter, PD; Stone, I; Sussman, D; Walter, RB; Westendorf, L; Yu, C; Zeng, W | 1 |
Chan, SM; Feng, W; Huang, M; Li, MX; Majeti, R; Mitchell, BS; Thomas, D | 1 |
Bari, R; Gan, K; Kang, G; Leung, W; Rujkijyanont, P; Sullivan, E; Turner, V | 1 |
Cong, YQ; Hu, XJ; Ma, LN; Wang, ZM | 1 |
Howell, SB; Wung, WE | 1 |
Holland, JF; Onuma, T; Waligunda, J | 1 |
14 other study(ies) available for cysteine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Topics: Cell Line, Tumor; Cysteine; Cystine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Nuclear Proteins; Sulfasalazine | 2022 |
A Ferroptosis-Inducing and Leukemic Cell-Targeting Drug Nanocarrier Formed by Redox-Responsive Cysteine Polymer for Acute Myeloid Leukemia Therapy.
Topics: Animals; Cysteine; Ferroptosis; Leukemia, Myeloid, Acute; Mice; Oxidation-Reduction; Paclitaxel; Polymers | 2023 |
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.
Topics: Animals; Cell Line, Tumor; Cysteine; Disease Models, Animal; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mutation; Protein Kinase Inhibitors; Reactive Oxygen Species | 2023 |
Unpaired Extracellular Cysteine Mutations of CSF3R Mediate Gain or Loss of Function.
Topics: Aged; Animals; Cysteine; Exome; Female; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Mice; Mutation, Missense; NIH 3T3 Cells; Phenotype; Receptors, Colony-Stimulating Factor | 2017 |
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Topics: 3T3-L1 Cells; Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; CCAAT-Enhancer-Binding Proteins; Cell Line; Cell Proliferation; Chickens; Cysteine; Gene Expression; Humans; Leukemia, Myeloid, Acute; Mice; Myeloid Cells; p300-CBP Transcription Factors; Pentacyclic Triterpenes; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-myb; Quail; Triterpenes | 2018 |
BETP degradation simultaneously targets acute myelogenous leukemia stem cells and the microenvironment.
Topics: ADP-ribosyl Cyclase 1; Animals; Antigens, CD34; Azepines; Bone Marrow; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Cysteine; Gene Expression Profiling; Glutathione; HL-60 Cells; Humans; Hyaluronan Receptors; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Male; Membrane Glycoproteins; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Nuclear Proteins; Oxidative Stress; Phosphorylation; Receptors, CXCR4; Thalidomide; THP-1 Cells; Thy-1 Antigens; Transcription Factors; U937 Cells | 2019 |
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
Topics: Adenosine Triphosphate; Biomarkers; Cysteine; Electron Transport Complex II; Energy Metabolism; Glutathione; Humans; Leukemia, Myeloid, Acute; Neoplastic Stem Cells; Oxidation-Reduction; Oxidative Phosphorylation; Reactive Oxygen Species; Succinate Dehydrogenase | 2019 |
Help from outside: cysteine to survive in AML.
Topics: Cysteine; Electron Transport Complex II; Humans; Leukemia, Myeloid, Acute; Stem Cells | 2019 |
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.
Topics: Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Benzodiazepines; Cell Cycle; Cross-Linking Reagents; Cysteine; Dimerization; Drug Design; Drug Resistance, Neoplasm; HEK293 Cells; HL-60 Cells; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Mice; Sialic Acid Binding Ig-like Lectin 3 | 2013 |
Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Cell Nucleolus; Cell Proliferation; Cysteine; Cytosol; Drug Resistance, Neoplasm; Flow Cytometry; Free Radical Scavengers; Humans; Leukemia, Myeloid, Acute; Mutation; Nuclear Proteins; Nucleophosmin; Oxides; Pyrazines; Reactive Oxygen Species; Tryptophan; Tumor Cells, Cultured | 2013 |
Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation.
Topics: Adolescent; Alleles; Analysis of Variance; Arginine; Child; Child, Preschool; Cysteine; Disease Progression; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; HLA-C Antigens; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, KIR2DL1; Transplantation, Homologous | 2013 |
[Expression of cysteine rich 61 and vascular endothelial growth factor genes in patients with myelodysplastic syndromes and their relationship.].
Topics: Bone Marrow Cells; Cysteine; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Vascular Endothelial Growth Factor A | 2009 |
Modulation of plasma cyst(e)ine by cisplatin.
Topics: Cell Division; Chromatography, High Pressure Liquid; Cisplatin; Cysteine; Humans; Leukemia, Myeloid, Acute; Neoplasms; Time Factors | 1983 |
Amino acid requirements in vitro of human leukemic cells.
Topics: Amino Acids; Asparaginase; Asparagine; Cells, Cultured; Culture Media; Cysteine; Female; Glutamine; Histidine; Humans; In Vitro Techniques; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Tritium; Tyrosine; Uridine | 1971 |